Aim & Scope
Cancer Studies and Molecular Medicine (CSMM) is a peer-reviewed, open-access journal published by Openventio Publishers, dedicated to advancing the understanding of cancer biology and its molecular basis. The journal provides a platform for researchers, clinicians, and academics to share original research, reviews, and clinical findings that deepen understanding of cancer at the molecular, cellular, and clinical levels.
Scope
CSMM welcomes original research articles, review papers, case reports, and short communications in areas including, but not limited to:
- Cancer Biology and Oncogenesis
- Molecular and Genetic Basis of Cancer
- Tumor Microenvironment and Metastasis
- Cancer Genomics, Proteomics, and Epigenetics
- Diagnostic and Prognostic Biomarkers in Cancer
- Cancer Pharmacology and Drug Development
- Precision and Personalized Oncology
- Cancer Immunotherapy and Immuno-Oncology
- Cancer Stem Cells and Tumor Heterogenesis
- Radiation Oncology
- Clinical Oncology and Translational Research
- Cancer Epidemiology and Prevention
Peer Review
All submissions undergo double-blind peer review by a minimum of two independent reviewers with relevant subject-matter expertise. The typical time from submission to first editorial decision is 12–14 weeks.
Originality
All manuscripts are screened for plagiarism using iThenticate prior to peer review.
Open Access and Licensing
CSMM is a fully open-access journal. Authors retain copyright of their work, published under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
Article Processing Charges
CSMM applies an Article Processing Charge based on the corresponding author's country income classification and article type, with full waivers available for authors from low-income countries, financial hardship cases, and students/early-career researchers. Full details are available on the Article Processing Charges and Waiver Policy page.
